A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

NCT05446740 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

324

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human

Interventions

BIOLOGICAL: GSK4382276A Dose level 1
BIOLOGICAL: GSK4382276A Dose level 2
BIOLOGICAL: GSK4382276A Dose level 3
BIOLOGICAL: GSK4382276A Dose level 4
BIOLOGICAL: GSK4382276A Dose level 5
BIOLOGICAL: GSK4382276A Dose level 6
BIOLOGICAL: GSK4382276A Dose level 7
BIOLOGICAL: GSK4382276A Dose level 8
BIOLOGICAL: GSK4382276A Dose level 9
BIOLOGICAL: GSK4382276A Dose level 10
COMBINATION_PRODUCT: FDQ21A-NH
COMBINATION_PRODUCT: FDQ22A-NH

Sponsor

GlaxoSmithKline

Collaborators

[object Object]